These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of cytochrome c oxidase subunits encoded by mitochondrial or nuclear DNA in the muscle of patients with zidovudine myopathy. Chariot P; Bonne G; Authier FJ; Marsac C; Gherardi R J Neurol Sci; 1994 Sep; 125(2):190-3. PubMed ID: 7807166 [TBL] [Abstract][Full Text] [Related]
3. Cytochrome c oxidase deficiency in the muscle of patients with zidovudine myopathy is segmental and affects both mitochondrial DNA- and nuclear DNA-encoded subunits. Yerroum M; Pham-Dang C; Authier FJ; Monnet I; Gherardi R; Chariot P Acta Neuropathol; 2000 Jul; 100(1):82-6. PubMed ID: 10912924 [TBL] [Abstract][Full Text] [Related]
4. Cytochrome c oxidase deficiency in zidovudine myopathy affects perifascicular muscle fibres and arterial smooth muscle cells. Chariot P; Le Maguet F; Authier FJ; Labes D; Poron F; Gherardi R Neuropathol Appl Neurobiol; 1995 Dec; 21(6):540-7. PubMed ID: 8745244 [TBL] [Abstract][Full Text] [Related]
5. Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part I: L-carnitine prevents the myotoxicity of AZT in vitro. Semino-Mora MC; Leon-Monzon ME; Dalakas MC Lab Invest; 1994 Jul; 71(1):102-12. PubMed ID: 7518879 [TBL] [Abstract][Full Text] [Related]
6. HIV or zidovudine myopathy? Gherardi R; Chariot P Neurology; 1994 Feb; 44(2):361-2; author reply 362-4. PubMed ID: 8309597 [No Abstract] [Full Text] [Related]
7. Fatal infantile mitochondrial myopathy and renal dysfunction due to cytochrome-c-oxidase deficiency. DiMauro S; Mendell JR; Sahenk Z; Bachman D; Scarpa A; Scofield RM; Reiner C Neurology; 1980 Aug; 30(8):795-804. PubMed ID: 6251406 [TBL] [Abstract][Full Text] [Related]
8. Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy. Chariot P; Monnet I; Gherardi R Ann Neurol; 1993 Oct; 34(4):561-5. PubMed ID: 8215243 [TBL] [Abstract][Full Text] [Related]
9. Suramin-induced weakness from hypophosphatemia and mitochondrial myopathy. Association of suramin with mitochondrial toxicity in humans. Rago RP; Miles JM; Sufit RL; Spriggs DR; Wilding G Cancer; 1994 Apr; 73(7):1954-9. PubMed ID: 8137223 [TBL] [Abstract][Full Text] [Related]
10. Zidovudine causes early increases in mitochondrial ribonucleic acid abundance and induces ultrastructural changes in cultured mouse muscle cells. d'Amati G; Lewis W Lab Invest; 1994 Dec; 71(6):879-84. PubMed ID: 7528833 [TBL] [Abstract][Full Text] [Related]
12. Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies. Pezeshkpour G; Illa I; Dalakas MC Hum Pathol; 1991 Dec; 22(12):1281-8. PubMed ID: 1748434 [TBL] [Abstract][Full Text] [Related]
13. Enzyme histochemical study of germanium dioxide-induced mitochondrial myopathy in rats. Yim SY; Lee IY; Kim TS Yonsei Med J; 1999 Feb; 40(1):69-75. PubMed ID: 10198609 [TBL] [Abstract][Full Text] [Related]
14. [Characterization of mitochondrial myopathies through the evaluation of the enzymatic activities involved in energy metabolism]. Pedroso FC; Campello AP; Werneck LC; Klüppel ML Arq Neuropsiquiatr; 1997 Jun; 55(2):249-57. PubMed ID: 9629385 [TBL] [Abstract][Full Text] [Related]
15. Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage. Dalakas MC; Leon-Monzon ME; Bernardini I; Gahl WA; Jay CA Ann Neurol; 1994 Apr; 35(4):482-7. PubMed ID: 8154877 [TBL] [Abstract][Full Text] [Related]
16. AZT causes tissue-specific inhibition of mitochondrial bioenergetic function. Modica-Napolitano JS Biochem Biophys Res Commun; 1993 Jul; 194(1):170-7. PubMed ID: 8101441 [TBL] [Abstract][Full Text] [Related]